Christopher Morgan, Senior Principal Advisor in Immunization at Jhpiego, shared a post on LinkedIn:
“Findings are in from 12 implementation research studies across 11 countries – and the evidence on HPV vaccine integration is compelling. Join us Wednesday, July 23 for the second in our three-part webinar series as we unpack the data on effectiveness and what that means for reaching priority populations equitably.
Integration Works: Cross-Country Insights from an Implementation Research Portfolio to Inform HPV Vaccination Programming – Webinar 2
This session dives deeper into cross-portfolio findings on effectiveness, exploring what the data show about HPV vaccine uptake and knowledge across studies. We’ll also examine how ‘baskets’ of integrated services were tailored to local contexts and the critical role integration plays in advancing equity for priority populations.
Date: Thursday, July 23 | 8:00 AM ET | 12:00 PM GMT
Register now.
Save the date: Our third and final webinar on September 23 will focus on translating findings into policy and practice. Don’t miss it!”
Other articles about HPV Vaccination on OncoDaily.